About this trial
Open-label, non-randomized, prospective, single-center, self-controlled clinical study.
Eligibility criteria
Qualifiers
Male or female subjects ≥ 25 years of age and ≤ 60 years of age.
Not pregnant or lactating and must be either post-menopausal, surgically sterilized, or using a medically acceptable form of birth control at least 3 months prior to enrollment (i.e., oral contraceptives, contraceptive implant, barrier methods with spermicide) or abstinence.
Desire to undergo treatments on abdomen and quadriceps and/or on hamstring and glutes for strength and tone muscles.
Subject agrees to maintain their weight within 5% of total body weight and avoid significant dietary or exercise changes during the study.
Disqualifiers
Pregnant or planning to become pregnant, having given birth less than 3 months ago, and/or breast feeding.
Medical disorder that would hinder the wound healing or immune response (such as blood disorder) including but not limited to arterial circulation disorders in lower limbs, inflammatory disease, etc.
Active malignancy or history of malignancy in the past 5 years.
Suffering from significant concurrent illness, such as cardiac disorders, sensory disturbances, diabetes (type I or II), epilepsy, lupus, porphyria, pertinent neurological disorders, uncontrolled hypertension, or liver or kidney disease (i.e. any disease state that in the opinion of the investigator may interfere with the anesthesia, treatment, or healing process).
Trial design
Treatments tested in this trial
- Pure Impact